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Abstract
Objectives: Although youth (12–24 years) in Sub-Saharan Africa have a high HIV risk, many have poor access to HIV testing
services and are unaware of their status. Our objective was to evaluate the proportion of adolescents (12–17 years) and
young adults (18–24 years) who underwent HIV testing and the prevalence among those tested in an urban adult
outpatient clinic with a routine HIV testing program in Durban, South Africa.
Design: We conducted a retrospective cross-sectional analysis of adolescent and young adult outpatient records between
February 2008 and December 2009.
Methods: We determined the number of unique outpatient visitors, HIV tests, and positive rapid tests among those tested.
Results: During the study period, 956 adolescents registered in the outpatient clinic, of which 527 (55%) were female.
Among adolescents, 260/527 (49%, 95% CI 45–54%) females underwent HIV testing compared to 129/429 (30%, 95% CI 26–
35%) males (p,0.01). The HIV prevalence among the 389 (41%, 95% CI 38–44%) adolescents who underwent testing was
16% (95% CI 13–20%) and did not vary by gender (p=0.99). During this period, there were 2,351 young adult registrations,
and of these 1,492 (63%) were female. The proportion consenting for HIV testing was similar among females 980/1,492
(66%, 95% CI 63–68%) and males 543/859 (63%, 95% CI 60–66%, p=0.25). Among the 1,523 (65%, 95% CI 63–67%) young
adults who underwent testing, the HIV prevalence was 22% (95% CI 19–24%) in females versus 14% in males (95% CI 11–
17%, p,0.01).
Conclusions: Although the HIV prevalence is high among youth participating in an adult outpatient clinic routine HIV
program, the uptake of testing is low, especially among 12–17 year old males. There is an urgent need to offer targeted,
age-appropriate routine HIV testing to youth presenting to outpatient clinics in epidemic settings.
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Introduction
Youth (12–24 years) are disproportionately affected by the HIV
epidemic in sub-Saharan Africa. [1,2] In South Africa, the HIV
prevalence rapidly rises through adolescence with an HIV
prevalence of 3% among 2–14 year olds, 15% among 15–24 year
olds, and 24% among those $25 year olds. [3] Despite the high
HIV prevalence, youth testing rates are low. [4,5] Compared to
47% of South Africans adults who report ever having an HIV test,
[6] only 25% of females and 15% of males 15–24 years old report
prior HIV testing [7].
In 2007 the World Health Organization (WHO) recommended
routine HIV testing among youth in epidemic settings, and South
Africa implemented an HIV testing initiative that proposed to
PLOS ONE | www.plosone.org 1 September 2012 | Volume 7 | Issue 9 | e45507mobilize youth and to ensure ‘youth friendly’ HIV testing services
–that is services and programs specifically designed for this
population. [6,8] Unfortunately, little guidance on the operatio-
nalization of youth routine testing, which refers to offering HIV
testing as a standard component of medical care, irrespective of
signs or symptoms, is provided in these recommendations.
To better understand testing in an urban adult outpatient clinic
with a routine HIV testing program for patients $12 years, we
evaluated the number of adolescents (12–17 years) and young
adults (18–24 years) who had HIV testing and the prevalence
among those tested in Durban, South Africa. We hypothesized
that adolescent and young adult females would have higher HIV
testing uptake and prevalence compared to adolescent and young
adult males [3,4].
Methods
This retrospective cross-sectional analysis was completed at
McCord Hospital, an urban medical center in Kwa-Zulu Natal,
the province with the highest HIV prevalence in South Africa. [9]
The overall estimated HIV prevalence in Kwa-Zulu Natal is 25%,
but is higher than 39% among women attending antenatal clinic.
[9] McCord is a government-subsidized, semi-private facility that
predominantly serves an urban population from the greater
Durban area. [10] McCord charges a subsidized fee for all service
and treatment and has a 142-bed inpatient ward and a well-
established HIV clinic. [10] McCord also has a general medical
outpatient clinic with separate adult and pediatric services that
serves 3,000–4,000 predominantly Zulu-speaking adults per
month. [10,11] The outpatient clinic provides a range of services
including primary health, urgent care, and emergency care for
trauma and critically ill patients; approximately 60% of patients
present for episodic care or for a single visit. [11] McCord has an
antenatal program that is separate from the outpatient clinic.
During the study period, patients paid an outpatient clinic
consultation fee (ZAR 280=US $40).
Patients $12 years are managed in the adult outpatient clinic.
Since 2008, the outpatient clinic has had a routine HIV testing
program and, per hospital guidelines, patients $12 years who are
not known to be HIV-infected should be offered routine HIV
testing on an opt-out basis at no additional charge. [11] Per South
African law, patients $12 years can consent for HIV testing
without guardian approval. [12] Prior to physician consultation,
dedicated HIV counselors obtained consent, pre- and post-test
counseling, and two concurrent rapid blood fingerprick HIV tests.
Newly-diagnosed HIV-infected patients were referred for CD4
testing at no additional fee and HIV clinic registration. HIV clinic
services were subsidized by the United States President’s
Emergency Plan for AIDS Relief (PEPFAR) and the KwaZulu-
Natal Department of Health. [10] Patients paid a subsidized
monthly fee for HIV clinic services [10].
For this analysis, we defined youth as those 12–24 years,
adolescents those 12–17 years, and young adults those 18–24
years. We reviewed outpatient clinic records between February
2008 and December 2009 and determined the number of unique
outpatient visitors, HIV tests, and positive rapid HIV tests in
adolescents (12–17 years) and young adults (18–24 years) when an
HIV counselor available (Monday-Saturday, 7:00 am-4:30 pm).
The study outcomes were the proportion that underwent an HIV
test and the HIV prevalence among adolescents and young adults
who underwent testing, stratified by gender. We used the Z-test to
compare proportions and the Cochran-Armitage test for trend to
assess changes in both the proportion of patients tested and the
HIV prevalence among those tested by age. All analyses were
carried out using R software (R version 2.11.1). Ethics approval
was obtained from the McCord Hospital, Children’s Hospital
Boston and Partners HealthCare Human Research Committees.
Given that the number of clinic registrations, HIV tests, and
positive rapid HIV tests were collected for clinic evaluation
purposes and analyzed in aggregate, individual patient consent
was not obtained. To our knowledge patients/guardians do not
consent to have their records used for research purposes at the
time of clinic registration. All data were analyzed in aggregate and
anonymously.
Results
From February 2008 to December 2009, there were 956
adolescent registrants (12–17 years) and of these 527 (55%) were
female (Table 1). Overall, 389 (41%) underwent HIV testing. Of
the adolescent females, 260/527 (49%, 95% CI 45–54%) un-
derwent HIV testing versus 129/429 (30%, 95% CI 26–35%)
adolescent males (p,0.01). The HIV prevalence among both male
and female adolescents who underwent testing was 16% (95% CI
13–20%, p=0.99).
During the same period, 2,351 young adults (18–24 years)
registered in the outpatient clinic and of these 1,492 (63%) were
female (Table 1). Of the young adult females, 980/1,492 (66%,
95% CI 63–68%) were HIV tested compared to 543/859 (63%,
95% CI 60–66%) young adult males (p=0.25). The HIV
prevalence among young adults who underwent testing was 19%
(95% CI 17–21%). The HIV prevalence was significantly higher
among young adult females who underwent testing (22%, 95% CI
19–24%) compared to young adult males who underwent testing
(14%, 95% CI 11–17%, p,0.01).
HIV testing was lowest among adolescents and steadily
increased among young adults for each gender (Figure 1a and
1b, dashed line). Overall, only 21% of presenting 12 year olds were
HIV tested compared to 63% of 24 year olds (data not shown).
The Cochran-Armitage test for trend revealed a significant
increase in the proportion of patients who completed HIV testing
with increasing age for females and males (p,0.01). The testing
among 12-year-old males was particularly low, with only 10% (7/
72) of males compared to 32% (25/78) of females completing HIV
testing (Figure 1a and 1b, dashed line). The low HIV testing rate
was in contrast to the high HIV prevalence, among those who
were tested, and this discrepancy held across all age groups for
each gender (Figure 1a and 1b, solid line, error bars represent 95%
confidence intervals). The HIV prevalence gradually increased
through young adulthood for each gender (solid line). The
Cochran-Armitage test for trend revealed a significant increase
in the HIV prevalence among females that were tested with
increasing age (p,0.01).
Discussion
We evaluated the proportion of adolescents and young adults
who had an HIV test and the prevalence among those tested in an
adult outpatient clinic with a routine HIV testing program in
Durban, South Africa. Although the HIV prevalence was 16%
among adolescents and 19% among young adults who underwent
testing, there was a large gap in HIV testing, particularly among
the adolescent males (12–17 years).
Despite recent studies that have shown that HIV testing may be
an efficacious strategy for identifying HIV-infected youth in the
primary clinic setting, [13] we observed low HIV testing among
adolescents in an outpatient routine testing program. Although the
proportion of youth who had HIV testing in our routine adult
testing program increased with age, only 21% of 12 year olds
Routine HIV Testing in South African Youth
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Durban, South Africa.
Total (%, 96% CI) Females (%, 95% CI) Males (%, 95% CI) p-value
Adolescent (12–17 years)
Total 956 (100) 527 (55, 52–58%) 429 (45, 42–48%)
HIV tested 389 (41, 38–44%) 260 (49, 45–54%) 129 (30, 26–35%) ,0.01
HIV-infected among those tested 62 (16, 13–20%) 42 (16, 12–21%) 20 (16, 10–23%) 0.99
Young Adult (18–24 years)
Total 2,351 (100) 1,492 (63, 61–65%) 859 (37, 35–39%)
HIV tested 1,523 (65, 63–67%) 980 (66, 63–68%) 543 (63, 60–66%) 0.25
HIV-infected among those tested 288 (19, 17–21%) 213 (22, 19–24%) 75 (14, 11–17%) ,0.01
The HIV testing and HIV-infected percentages represent column percentages.
doi:10.1371/journal.pone.0045507.t001
Figure 1. Proportion of females and males who underwent testing and the HIV prevalence among those tested, by age. The dashed
line represents the proportion who underwent HIV testing by age. The solid line is the HIV prevalence among those tested with error bars
representing 95% confidence intervals. Figure 1a–Females. Figure 1b–Males.
doi:10.1371/journal.pone.0045507.g001
Routine HIV Testing in South African Youth
PLOS ONE | www.plosone.org 3 September 2012 | Volume 7 | Issue 9 | e45507underwent testing. The low HIV testing among the adolescents
could have resulted from multiple individual, caretaker, social/
cultural, clinic, and community barriers. On an individual level,
youth may decline HIV testing because they do not consider
themselves at risk for infection because they are not sexually active,
or because they are asymptomatic. [14,15,16] The perceived
association between sexual debut and HIV risk is especially
concerning for the subset of adolescents who have late diagnosis of
perinatally-acquired infection. [15] Caretakers and healthcare
workers can also limit HIV testing opportunities if they do not
think the youth is at risk for HIV infection. [15] Uncertainty about
the legal age of consent for HIV testing and the informed consent
process, [17] especially for youth presenting with caretakers, can
also be barriers. Additional barriers to youth testing include
concern for confidentiality, stigma of using a testing facility,
unfriendly clinic staff, and that South African youth $12 years are
regarded as adults and managed in adult healthcare programs
[16,18,19,20].
HIV testing for adolescent females in this outpatient routine
HIV testing program was higher than for adolescent males.
Previous studies have shown the higher overall testing rates among
females in Sub-Saharan Africa. [3,21,22,23] In particular, female
youth in Kenya [14] and South Africa [4,5,7] have also been
reported to have higher HIV testing rates than male youth. The
difference in HIV testing by gender is thought to occur because
female youth are more likely to be offered testing, [14] in part due
to their participation in antenatal programs. [5] The high HIV
testing among young adult females in our outpatient clinic study is
not due to antenatal testing which is a separate program at our
study site. The gender differential in HIV testing in our study
highlights the importance of targeting routine testing programs
specifically to adolescent males, who are reported to have a lower
median age of sexual debut and higher number of partners than
adolescent females [4].
The low uptake of routine HIV testing among youth represents
a missed opportunity for testing and undermines current South
African efforts to extend counseling and testing to this population
that experiences a high burden of new HIV infections.
[1,2,6,16,20,24] Testing services that are designed for youth are
urgently needed to increase testing uptake. [1,2,16,20,24] The
WHO framework for youth-friendly health services includes
programs that are accessible, equitable, acceptable, appropriate,
comprehensive, effective, and efficient for young people. [25] In
practice, youth friendly testing services, should be easily accessible
to young people by offering appropriate hours and free services,
staffed by providers who are motivated and trained to meet the
needs of youth, and involve youth in the development of services.
[13,16,20,24,26,27,28,29] In addition to being the entry point to
HIV treatment, youth HIV testing services are valuable to provide
HIV prevention counseling, [20,30] promote regular patterns of
HIV testing in adulthood for HIV-negative youth, and impact the
dramatic rise in HIV incidence in transition to adulthood.
Understanding the barriers to testing uptake, developing youth-
friendly HIV testing services, and optimizing the delivery of youth
HIV testing is challenging. Involving South African youth in
research to inform HIV testing programs is crucial yet requires
parental consent for those #18 years, which can be difficult to
obtain and limits participation. [2,24,31,32,33] Although there are
no specific youth HIV testing studies, designing a standardized
youth HIV testing program seems impractical because of the
developmental heterogeneity of this population. [19,20,34] Opti-
mizing the venue for youth HIV diagnostic services, such as
school-based or mobile unit testing, may improve youth testing
opportunities. [20,35,36] Also, the need for dedicated youth health
care professionals, clinics, and units, including HIV services,
requires further attention in resource-limited settings [19,20].
The HIV prevalence among adolescents and young adults
participating in this outpatient routine HIV testing program was
high. As reported in national data, the HIV prevalence rose
steadily and disproportionately among young adult females. [3,4]
The high HIV prevalence among young adult females as
compared to young adult males has been attributed to a range
of factors including differences in biological susceptibility, higher
rates of intergenerational sex, and lower use of condoms.
[37,38,39] As compared to the young adults, the HIV prevalence
among adolescents did not differ by gender. It is possible that the
similar adolescent prevalence across gender is reflective of late
progressors who acquired HIV perinatally. [15] In our analysis,
the rise in HIV prevalence among those tested begins at 16–17
years which corresponds to the median age of sexual debut in
South Africa [4].
This analysis is based on cross-sectional clinic data and has
several limitations. The study site is not representative of the large
volume primary healthcare clinics where care is free and the HIV
testing uptake and prevalence would likely be different. Although
routine HIV testing for patients .12 years is clinic policy, we
cannot determine if all the youth who presented were in fact
offered HIV testing. The retrospective and aggregate nature of the
study precludes analyzing the individual factors associated with
routine HIV testing among youth. For example, we do not know
the reason the youth presented to the clinic, if they presented with
their caretaker, if they refused HIV testing, or if they had a CD4
count and enrolled in continuity HIV services for those who were
newly-diagnosed HIV-infected. It is possible that HIV testing was
preferentially offered by healthcare workers or requested by youth
with a high suspicion for infection. We cannot assess the impact of
the caretaker nor structural clinic barriers on routine youth HIV
testing.
Given the large rise and high HIV prevalence among youth,
optimizing HIV testing is essential for effective treatment and
prevention and tackling the HIV epidemic in this population.
There is an urgent need to offer directed, comprehensive, and age-
appropriate HIV testing to youth presenting to outpatient clinics
in epidemic settings in order to increase HIV knowledge,
encourage regular HIV testing, and diagnose and link to care
those who are HIV-infected.
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